WO2001022943A8 - A slow release pharmaceutical composition comprising a magnesium oxychloride cement - Google Patents

A slow release pharmaceutical composition comprising a magnesium oxychloride cement

Info

Publication number
WO2001022943A8
WO2001022943A8 PCT/ZA2000/000180 ZA0000180W WO0122943A8 WO 2001022943 A8 WO2001022943 A8 WO 2001022943A8 ZA 0000180 W ZA0000180 W ZA 0000180W WO 0122943 A8 WO0122943 A8 WO 0122943A8
Authority
WO
WIPO (PCT)
Prior art keywords
release pharmaceutical
slow release
pharmaceutical composition
oxychloride cement
magnesium oxychloride
Prior art date
Application number
PCT/ZA2000/000180
Other languages
French (fr)
Other versions
WO2001022943A1 (en
Inventor
Henry John Davis
Original Assignee
H J Davis Fine Chemicals Cc
Henry John Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H J Davis Fine Chemicals Cc, Henry John Davis filed Critical H J Davis Fine Chemicals Cc
Priority to AU78874/00A priority Critical patent/AU7887400A/en
Publication of WO2001022943A1 publication Critical patent/WO2001022943A1/en
Publication of WO2001022943A8 publication Critical patent/WO2001022943A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to slow release pharmaceutical compositions. More particularly it relates to the combination of hygroscopic solid, liquid or gaseous pharmaceutically active substances with solidifying materials of the type known as Sorel cement thereby to produce solid compositions which, when taken orally, has slow releasing properties in respect of the substance so incorporated into the composition.
PCT/ZA2000/000180 1999-09-29 2000-09-29 A slow release pharmaceutical composition comprising a magnesium oxychloride cement WO2001022943A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78874/00A AU7887400A (en) 1999-09-29 2000-09-29 A slow release pharmaceutical composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA99/6190 1999-09-29
ZA996190 1999-09-29

Publications (2)

Publication Number Publication Date
WO2001022943A1 WO2001022943A1 (en) 2001-04-05
WO2001022943A8 true WO2001022943A8 (en) 2001-07-19

Family

ID=25587935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2000/000180 WO2001022943A1 (en) 1999-09-29 2000-09-29 A slow release pharmaceutical composition comprising a magnesium oxychloride cement

Country Status (2)

Country Link
AU (1) AU7887400A (en)
WO (1) WO2001022943A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387412B1 (en) * 2000-04-14 2002-05-14 Agri-Nutrients Technology Group, Inc. Storage stable animal mineral granules
IL149978A0 (en) * 2002-06-02 2002-12-01 Biotan Biocides For Paints And A biocide and method for making the same
GB0705792D0 (en) * 2007-03-26 2007-05-02 Orthogem Ltd Magnesium oxide cement
CN101278928B (en) * 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 Medicament composition containing levocarnitine or its derivatives and use thereof
FR2931361B1 (en) 2008-05-20 2012-08-31 Menvielle Bourg Fabienne Joanny MAGNESIUM-BASED SYSTEM AND ITS USE IN COSMETICS
FR2931359B1 (en) 2008-05-20 2012-12-21 Menvielle Bourg Fabienne Joanny USE OF MATRIX FOR EXTENDED RELEASE MAGNESIUM ORAL DELIVERY, AND COMPOSITION CONTAINING SAME
US9339667B2 (en) * 2009-02-18 2016-05-17 Sea Qiq As Mixture of inorganic compounds, preparations containing the mixture and use of the mixture
EP2813217A1 (en) 2013-06-11 2014-12-17 Fabienne Joanny Menvielle-Bourg Composition for oral administration of magnesium, in association with a composition for the treatment of type 2 diabetes and its complications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123693B (en) * 1982-07-20 1987-05-13 Nat Res Dev Sustained release device
US5273547A (en) * 1988-04-29 1993-12-28 Carus Corporation Sorel cementitious composition which time releases permanganate ion
GB8820242D0 (en) * 1988-08-25 1988-09-28 Kent B E Sustained release device

Also Published As

Publication number Publication date
AU7887400A (en) 2001-04-30
WO2001022943A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
AU2002210993A1 (en) Medicinal compositions for concominant use as anticancer agents
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
WO2008052033A3 (en) Ibuprofen composition
MX2008012731A (en) Fast release paracetamol tablets.
HUP0302226A3 (en) Substituted pyrrolopyridinone dervatives useful as phosphodiesterse inhibitors, their intermediates and pharmaceutical compositions containing the compounds
HUP0102676A3 (en) Solid, quick dissolving pharmaceutical compositions containing cetrizine
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
CA2361402A1 (en) Bis-sulfonamides
WO2007017331A3 (en) Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
IL153428A0 (en) Solid valsartan pharmaceutical compositions
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
AR061093A1 (en) CALCIUM COMPOSITIONS
PL394600A1 (en) Vinylazocycloalkanyl compound, process for the preparation thereof, its use and pharmaceutical composition
EP2017269A9 (en) A pharmaceutical composition comprising form II crystalline Ritonavir and a preparation thereof
WO2001022943A8 (en) A slow release pharmaceutical composition comprising a magnesium oxychloride cement
AU2001275810A1 (en) The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
CA2429639A1 (en) Stable azithromycin monohydrate
WO2004108084A3 (en) Polymorphic forms of naltrexone
ZA200203077B (en) Ciclesonide contained pharmaceutical composition for application to mucosa.
GB2368014B (en) Pharmaceutical composition containing citalopram
HUP0301590A3 (en) Nonpeptide substituted spirobenzoazepines as vasopressin antagonists, pharmaceutical compositions containing them and their preparation
WO2003028624A3 (en) Levothyroxine compositions and methods
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
MY140724A (en) Novel arylethene-sulfonamides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: REVISED TITLE RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP